Ranked #1
Unraveling the Significance of Mismatch Repair Deficiency in Women With Endometrioid-type Endometrial Adenocarcinoma
Unraveling the Significance of Mismatch Repair Deficiency in Women With Endometrioid-type Endometrial Adenocarcinoma
This podcast discusses the study by McMeekin and colleagues regarding their analysis of the prognostic and predictive im... Read more
20 Jun 2016
•
10mins
Ranked #2
Osteonecrosis in Pediatric Acute Lymphoblastic Leukemia
Osteonecrosis in Pediatric Acute Lymphoblastic Leukemia
This podcast summarizes the incidence and long-term outcome of osteonecrosis in a largeprospective study of children tre... Read more
26 Sep 2011
•
10mins
Similar Podcasts
Ranked #3
Using the CLIC Study of Outcome in Advanced Stages of Mycosis Fungoides and Sezary Syndrome to Guide Treatment And Clinical Research
Using the CLIC Study of Outcome in Advanced Stages of Mycosis Fungoides and Sezary Syndrome to Guide Treatment And Clinical Research
This podcast reviews the current knowledge of staging and prognosis of mycosis fungoides and Sezary syndrome and evaluat... Read more
5 Oct 2015
•
8mins
Ranked #4
Resuming Life After Cancer Therapy: Treatment-Free Survival
Resuming Life After Cancer Therapy: Treatment-Free Survival
Treatment-free survival is a novel endpoint in immunotherapy. TRANSCRIPT This JCO Podcast provides observations and comm... Read more
10 Dec 2019
•
8mins
Ranked #5
Targeting the VEGF Receptor in Colon Cancer: Lessons Learned from Negative Trials
Targeting the VEGF Receptor in Colon Cancer: Lessons Learned from Negative Trials
In this podcast, Dr. Neal J. Meropol provides his perspective on two large randomized studies of vatalanib in patients w... Read more
4 Apr 2011
•
11mins
Ranked #6
Uterine lavage: a new approach to gynecologic cancer detection?
Uterine lavage: a new approach to gynecologic cancer detection?
Recent findings represent an important and exciting step in applying the rapid advance of sequencing technologies to gen... Read more
9 Nov 2015
•
7mins
Ranked #7
High Reward, High Toxicity: Combination Pembrolizumab and Lenvatinib in Advanced Endometrial Cancer
High Reward, High Toxicity: Combination Pembrolizumab and Lenvatinib in Advanced Endometrial Cancer
The combination of pembrolizumab and lenvatinib is a promising second line option for metastatic or recurrent MSS endome... Read more
1 Mar 2020
•
7mins
Ranked #8
Why are Fellows' Burnout Rates as High as Those of Practicing Oncologists?
Why are Fellows' Burnout Rates as High as Those of Practicing Oncologists?
This JCO Podcast provides observations and commentary on the JCO article, "Oncology Fellows' Career Plans, Expectations ... Read more
21 Jul 2014
•
8mins
Ranked #9
Is This Nomogram Ready To Roll?
Is This Nomogram Ready To Roll?
In this podcast, Dr. Hudis reviews the use of a novel nomogram to predict the benefits of postoperative adjuvant radiati... Read more
25 Jun 2012
•
14mins
Ranked #10
Shared Risk Factors in Cancer and Cardiovascular Disease: Can We Make a Difference?
Shared Risk Factors in Cancer and Cardiovascular Disease: Can We Make a Difference?
This podcast examines the growing evidence to support the link between risk factors for cardiovascular disease and cance... Read more
12 Jul 2017
•
8mins
Ranked #11
Personalized Therapy for Breast Cancer: Is It Really Happening?
Personalized Therapy for Breast Cancer: Is It Really Happening?
This Podcast reviews and comments on the use of the National Comprehensive Cancer Network (NCCN) Breast Cancer Outcome D... Read more
9 May 2012
•
8mins
Ranked #12
Immunohistochemical Double Hit Score in Diffuse Large B-Cell Lymphoma: The Potential to Screen All Tumors for High-Risk Biology
Immunohistochemical Double Hit Score in Diffuse Large B-Cell Lymphoma: The Potential to Screen All Tumors for High-Risk Biology
This podcast summarizes and places in clinical context two studies describing straightforward immunohistochemical method... Read more
4 Sep 2012
•
11mins
Ranked #13
Anti-EGFR Monoclonal Antibodies in the First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The PEAK Experience
Anti-EGFR Monoclonal Antibodies in the First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The PEAK Experience
In this podcast, I will discuss first-line usage of anti-EGFR therapies in metastatic colorectal cancer in the context o... Read more
31 Mar 2014
•
8mins
Ranked #14
The Dark Side of del(5q) MDS
The Dark Side of del(5q) MDS
This podcast will discuss the basic background of myelodysplastic syndromes and the clinical implications of TP53 mutati... Read more
25 Apr 2011
•
8mins
Ranked #15
Hard to RECIST: Updating and Simplifying Primary Tumor Response Guidelines for the Revised International Neuroblastoma Response Criteria (INRC)
Hard to RECIST: Updating and Simplifying Primary Tumor Response Guidelines for the Revised International Neuroblastoma Response Criteria (INRC)
This podcast reviews the accompanying article to provide the audience an understanding of the data and rationale to supp... Read more
11 Jan 2016
•
9mins
Ranked #16
The First Prospective Trial of Proton Therapy for Children With Rhabdomyosarcoma: What We Learn From Preliminary Results
The First Prospective Trial of Proton Therapy for Children With Rhabdomyosarcoma: What We Learn From Preliminary Results
This is a prospective study of proton radiotherapy for rhabdomyosarcoma showing equivalent efficacy with photon treatmen... Read more
25 Nov 2014
•
8mins
Ranked #17
Clinical Drug Development for Non-Muscle-Invasive Bladder Cancer…Definitions Matter
Clinical Drug Development for Non-Muscle-Invasive Bladder Cancer…Definitions Matter
This podcast reviews the International Bladder Cancer Group’s recommendations regarding definitions and endpoints for th... Read more
25 Jan 2016
•
9mins
Ranked #18
Who Needs What Therapy? The Elusive Search for Predictive Markers
Who Needs What Therapy? The Elusive Search for Predictive Markers
Loss of PTEN expression did not predict resistance to trastuzumab in early stage HER2 positive breast cancer in the larg... Read more
6 May 2013
•
8mins
Ranked #19
Nivolumab: Promising Survival Signal Coupled with Limited Toxicity Raises Expectations
Nivolumab: Promising Survival Signal Coupled with Limited Toxicity Raises Expectations
This JCO podcast provides observations and commentary on the JCO article, Survival, Durable Tumor Remission, and Long-Te... Read more
3 Mar 2014
•
10mins
Ranked #20
The Emerging Role of Gallium-68 Somatostatin-Receptor PET Imaging in Neuroendocrine Tumors
The Emerging Role of Gallium-68 Somatostatin-Receptor PET Imaging in Neuroendocrine Tumors
This podcast describes the evolving role of Gallium-68 somatostatin-receptor PET imaging in the evaluation of patients w... Read more
28 Dec 2015
•
8mins